XClose

Cancer

Home
Menu

News

Experimental model to study the development of brain cancer in children

Researchers from UCL, the German Center for Neurodegenerative Diseases (DZNE) and McGill University, Montreal have published details of a novel laboratory model that replicates the hallmarks of paediatric brain cancer. The research results, published in Cancer Cell, could pave the way for a better understanding of processes driving the development of cancer.

Publication date:

Rucaparib boosts progression-free survival in recurrent ovarian cancer

The highly anticipated results from the ARIEL3 clinical trial, evaluating use of rucaparib among women with advanced ovarian cancer, have been published in The Lancet. According to study data, maintenance therapy with rucaparib (Rubraca, Clovis Oncology) significantly extended progression-free survival among women with platinum-sensitive recurrent ovarian cancer. 

Publication date:

First prostate cancer patient scanned using hyperpolarised MRI in Europe

A University College Hospital prostate cancer patient has undergone diagnosis using hyperpolarised Magnetic Resonance Imaging (MRI) as part of a UCL clinical trial. Led by Dr Shonit Punwani, the trial aims to develop more accurate and personalised treatment for cancer.

Publication date: